Disadvantages
In certain circumstances, liquid biopsies may not be as sensitive as IHC or FISH for testing NTRK gene fusions [1, 3]. If circulating DNA and RNA volume is low (e.g., when the tumour volume is low), a test failure or false negative may result. However, enrichment methods (e.g., hybrid capture, etc.) may be used to increase detection [4].
References
- Hofman P. Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology. Cancers (Basel) 2017; 9: pii: E154. doi: 110.3390/cancers9110154.
- Merker JD, Oxnard GR, Compton C et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol 2018; 36: 1631-1641.
Hechtman JF. NTRK insights: best practices for pathologists. Mod Pathol. 2022; 35(3):298-305.
Bruno R, Fontanini G. Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review. Diagnostics (Basel). 2020 Jul 27;10(8):521.